Figure 10.
In vitro validation of the targets using MTT assay and qPCR. (A) MTT assay to measure cell viability in PC12 cells after treatment with AU at 0 to 160 μM concentrations (In comparison with the control group, *P < 0.05, and ** P < 0.01). (B) MTT assay to measure PC12 cell proliferation after treatment with AU at 0 to 5 mM concentrations (In comparison with the control group, *P < 0.05, and ** P < 0.01). (C) Quantitative analysis of BTN3A2, AURKA, PLA2G7, ERAP2, CXCL10, MARCO, MAP-2, and βIII-tubulin gene expression in HFLS cells by real-time PCR (In comparison between two groups, *P < 0.05, and ** P < 0.01). (D) Quantitative analysis of BTN3A2, AURKA, PLA2G7, CXCL10, MARCO, MAP-2, and βIII-tubulin gene expression in PC12 cells by real-time PCR (In comparison between two groups, *P < 0.05, and ** P < 0.01).
